Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Clinical Implications of Bovine Spongiform Encephalopathy

Chris MacKnight
Clinical Infectious Diseases
Vol. 32, No. 12 (Jun. 15, 2001), pp. 1726-1731
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4482640
Page Count: 6
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
Clinical Implications of Bovine Spongiform Encephalopathy
Preview not available

Abstract

Bovine spongiform encephalopathy (BSE) is a new prion disease that was first identified in the United Kingdom in 1987. Its appearance was likely caused by changes in the rendering process used to produce a meat and bone supplement for cattle, changes that allowed this prion to enter the bovine food supply. Despite measures that were made to reduce the risk to humans, a new variant of Creutzfeldt-Jakob disease appeared in the mid-1990s and has been linked to BSE. Although the extent of the disease's impact on humans is not yet known, current estimates predict that there will be 136,000 cases of this fatal disease by the year 2040. The risk to humans of medications produced with bovine materials, gelatin, and blood transfusion is unknown.

Page Thumbnails

  • Thumbnail: Page 
1726
    1726
  • Thumbnail: Page 
1727
    1727
  • Thumbnail: Page 
1728
    1728
  • Thumbnail: Page 
1729
    1729
  • Thumbnail: Page 
1730
    1730
  • Thumbnail: Page 
1731
    1731